Dimethylsilane polyamines, a new class of potential anticancer drugs: Effects on the growth of Lewis lung carcinoma in mice

International Journal of Oncology

Volumn 11, Issue 4, 1997, Pages 835-841

  Seiler, Nikolaus ^a   Douaud, Fabienne ^a   Havouis, Rene ^a   Roch, Nathalie L E ^b   Renault, Jacques ^c   Vaultier, Michel ^b   Moulinoux, Jacques Philippe ^a,c  

^a Grp de Rech en Therapeutique A   (France)

^b Chimie et Photonique Moleculaires Rennes   (France)

^c UNIVERSITÉ DE RENNES 1   (France)

Author keywords

Dimethylsilane polyamines; Lewis lung carcinoma

Indexed keywords

(6 AMINO 3 AZAHEXYL) (7 AMINO 4 AZAHEPTYL)DIMETHYLSILANE; ANTINEOPLASTIC AGENT; POLYAMINE DERIVATIVE; SPERMINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; FEMALE; HYPOTHERMIA; INTRAPERITONEAL DRUG ADMINISTRATION; LEWIS CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030885821     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Bachrach U and Heimer YM (eds): The Physiology of Polyamines. Vol. 2. CRC Press, Boca Raton, 1988.
2. Douaud F, Le Roch N, Renault J, Havouis R, Vaultier M, Moulinoux JP and Seiler N: Dimethylsilanc polyamines: cytostatic compounds with potentials as anticancer drugs. Anticancer Drug Des (In press).
3. Basu HS and Marton LJ: The interaction of spermine and pentamines with DNA. Biochem J 244: 243-246, 1987.
4. Basu HS, Schwietert HCA, Feuerstein BG and Marton LJ: Effects of variation in the structure of spermine on the association with DNA and the induction of DNA conformational changes. Biochcm J 269: 329-334, 1990.
5. Delcros JG, Vaultier M, Le Roch N, Havouis R, Moulinoux JP and Seiler N: Bis(7-amino-4-azaheptyl)dimethylsilane: a new tetramine with polyamine-like features. Effects on cell growth. Anti-cancer Drug Des 12: 35-48, 1997.
6. Seiler N, Delcros JG, Vaultier M, Le Roch N, Havouis R, Douaud F and Moulinoux JP: Bis(7-amino-4-azaheptyl)dimethylsilane and bis(7-ethylaimino-4-azaheptyl)-dimethylsilane: inhibition of tumor cell growth in vitro and in vivo. Cancer Res 56: 5624-5630, 1996.
7. Watanabe S, Kusama-Egushi K, Kobayashi H and Igarashi K: Estimation of polyamine binding to macromolecules and ATP in bovine lymphocytes and rat liver. J Biol Chem 266: 20803-20809, 1991.
8. Seiler N: Pharmacological properties of the natural polyamines and their depletion by biosynthesis inhibitors as a therapeutic approach. Prog Drug Res 37: 107-159, 1991.
9. Bey P, Danzin C and Jung MJ: Inhibition of basic amino acid decarboxylases involved in polyamine biosynthesis. In: Inhibition of Polyamine Metabolism. McCann PP, Pegg AE and Sjoerdsma A (eds). Academic Press, Orlando, pp1-31, 1987.
10. Sarhan S, Knödgen B and Seiler N: The gastrointestinal tract as polyamine source for tumor growth. Anticancer Res 9: 215-224, 1989.
11. Bergeron RJ, McManis JS, Liu CZ, Feng Y, Weimar WR, Luchetta GR, Wu Q, Ortiz-Ocasio J, Vinson JRT, Kramer D and Porter C: Antiproliferative properties of polyamine analogues: a structure-activity study. J Med Chem 37: 3464-3476, 1994.
12. Seiler N: Functions of polyamine acetylation. Can J Physiol Pharmacol 65: 2024-2035, 1987.
13. 1-acetyltransferase - the turning point in polyamine metabolism. FASEB J 7: 653-661, 1993.
14. Eastman A: Reevaluation of interaction of cis-dichloro (ethylenediamine)platinum(II) with DNA. Biochemistry 25: 3912-3915, 1986.
15. 11-bisethylnorspermine with cisdiaminedichloroplatinum(II) against murine neoplastic cell lines in vitro and in vivo. Cancer Lett 99: 99-107, 1996.
16. 11-bis(ethyl)norspennine against human melanoma xenografts and possible biochemical correlates. Cancer Res 53: 581-586, 1993.
17. Igarashi K, Koga K, He Y, Shimogori T, Ekimoto H, Kashiwagi K and Shirahata A: Inhibition of the growth of various human and mouse tumor cells by l,15-bis(ethylamino)-4,8,12triazapentadecane. Cancer Res 55: 2615-2619, 1995.
18. Regenass U, Mett H, Stanek J, Mueller M, Kramer D and Porter CW: CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity. Cancer Res 54: 3210-3217, 1994.